Video

Dr. Jennifer Miles-Thomas discusses the gender pay gap in urology

Author(s):

Urology Times staff
Conference|LUGPA Annual Meeting
Current Time 0:00
Duration 0:51
Loaded: 19.03%
Stream Type LIVE
Remaining Time 0:51
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
    • en (Main), selected

    At the 2021 LUGPA Annual Meeting Jennifer Miles-Thomas, MD, FPMRS, president, Urology Of Virginia, participated in a panel discussion titled, “Strategies to Recruit and Retain Female Urologists in your Practice.” In this video, Miles-Thomas discusses the gender pay gap in urology.

    Related Videos
    Professor Dickon Hayne shares data on mitomycin plus BCG in high-risk NMIBC
    Professor Dickon Hayne shares data on mitomycin plus BCG in high-risk NMIBC
    Thomas Powles, MBBS, MRCP, MD, on efficacy of sasanlimab plus BCG in BCG-naïve NMIBC
    Thomas Powles, MBBS, MRCP, MD, on efficacy of sasanlimab plus BCG in BCG-naïve NMIBC
    Andrew Armstrong, MD, shares 5-year data on enzalutamide plus ADT in mHSPC
    Andrew Armstrong, MD, shares 5-year data on enzalutamide plus ADT in mHSPC
    Professor Dickon Hayne on bladder cancer data to watch for at ASCO 2025
    Professor Dickon Hayne on bladder cancer data to watch for at ASCO 2025
    Andrew Armstrong, MD, previews key prostate cancer data at ASCO 2025
    Andrew Armstrong, MD, previews key prostate cancer data at ASCO 2025
    Maria Uloko, MD, discusses the lack of resident training on female sexual dysfunction
    Maria Uloko, MD, discusses the lack of resident training on female sexual dysfunction
    Woman talking with doctor | Image Credit: © Liudmila Dutko - stock.adobe.com
    Alternative treatments and patient communication for genitourinary syndrome of menopause
    Yahir A. Santiago-Lastra, MD, answers a question during a Zoom video interview
    Yahir A. Santiago-Lastra, MD, discusses barriers to vaginal estrogen access
    Woman talking with a doctor | Image Credit: © Liudmila Dutko - stock.adobe.com
    Expert discusses genitourinary syndrome of menopause guidelines
    5 key trial insights from AUA 2025
    5 key trial insights from AUA 2025
    Related Content
    Data supports mitomycin plus BCG as alternative to BCG alone in NMIBC
    June 5th 2025

    Data supports mitomycin plus BCG as alternative to BCG alone in NMIBC

    Hannah Clarke
    According to the authors, the mitomycin/BCG regimen could alleviate some of the burden of the global BCG shortage.
    Pearls & Perspectives: Understanding and Improving Pelvic Health, with Diane Newman, DNP
    June 2nd 2025

    Pearls & Perspectives: Understanding and Improving Pelvic Health, with Diane Newman, DNP

    Amy M. Pearlman, MD
    Amy L. Shaver, PhD, PharmD, MPH
    June 5th 2025

    GLP-1 agonist use is rising in men with prostate cancer

    Benjamin P. Saylor
    In 2015, 1245 patients had prostate cancer and had also initiated a GLP-1 or GIP/GLP-1 receptor agonist compared with 69,808 patients in 2024.
    Pearls & Perspectives: Expanding BPH care & patient choice, with Kevin Zorn, MD, at AUA 25
    May 4th 2025

    Pearls & Perspectives: Expanding BPH care & patient choice, with Kevin Zorn, MD, at AUA 25

    Amy M. Pearlman, MD Kevin C. Zorn, MD, FRCSC, FACS
    Urologists discuss innovative BPH treatments, emphasizing personalized care, and the importance of ejaculatory preservation.
    Doctor giving a consultation to a patient and explaining medical informations and diagnosis | Image Credit: © Pcess609 - stock.adobe.com
    June 4th 2025

    ARANOTE: Darolutamide improves HRQoL in mHSPC

    Benjamin P. Saylor
    Treatment with darolutamide was found to extend median time to deterioration of FACT-P total score by 5.1 months vs placebo
    Rana R. McKay, MD, FASCO
    June 4th 2025

    COMRADE: Olaparib plus radium-223 improves rPFS in mCRPC

    Benjamin P. Saylor
    “This was a positive study, resulting in a statistically significant improvement in the primary end point of rPFS in the intent-to-treat population," said Rana R. McKay, MD, FASCO.
    © 2025 MJH Life Sciences

    All rights reserved.